Notably, both triple-negative cancer cells showed a significant reduction of the doxo-induced Snail level in cells cotreated with ABT-888 and doxo, suggesting a positive effect of the PARP inhibitor as antitumor agent in this subset of breast tumors. Here, PARP1 is linked to breast neoplasm.